RAIN ENHANCEMENT TECHNO-CL A

RAIN · NASDAQ

Updated at 2026-10-13 15:18:11

$0.65-4.76%
Today's High
$0.72
Today’s Low
$0.65
RAIN ENHANCEMENT TECHNO-CL A (RAIN) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$0.68
Previous Close
$0.68
Volume
32.27K
Market Cap
$8.06M
P/E Ratio
--
EPS
$-1.23

Previous Day Range

$0.67$0.71

52-Week Range

$0.64$8.52

Company Overview

Sector
INDUSTRIALS
Industry
Machinery
Sub-industry
POLLUTION & TREATMENT CONTROLS
Headquarters
4851 TAMIAMI TRAIL N, NAPLES, FL, UNITED STATES, 34103
Country
US
Listing Date
2025-01-02
Fiscal Year End
December
Shares Outstanding
10.34M
CIK
0002028293

Rain Therapeutics Inc., a clinical-stage precision oncology company, is dedicated to developing therapies that target oncogenic drivers in the United States. The company is headquartered in Newark, California.

Financial Metrics

Revenue

2026-06-30

$0

2026-03-31

$10.5K

2025-12-31

$0

2025-09-30

$0

Operating Expenses

2026-06-30

$3.05M

2026-03-31

$1.83M

2025-12-31

$4.06M

2025-09-30

$1.58M

Net Income

2026-06-30

-$3.24M

2026-03-31

-$1.86M

2025-12-31

-$4.45M

2025-09-30

-$2.2M

Net Profit Margin

2026-06-30

--

2026-03-31

-17.71K%

2025-12-31

--

2025-09-30

--

Earnings Per Share

2026-06-30

$-0.40

2026-03-31

$-0.23

2025-12-31

$-0.54

2025-09-30

$-0.29

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$2.92M

2026-03-31

-$1.7M

2025-12-31

-$4.48M

2025-09-30

-$1.95M

Effective Tax Rate

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.